Navigation Links
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex
Date:5/13/2010

The joint venture Abbymex is announced by Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. to provide a consistent supply of logwood extract used in the production of hematoxylin and hematine. Hematoxylin is a key ingredient in stains used by biological laboratories for Pap smear tests and hematine is used to dye medical sutures. Abbey Color is the world’s largest manufacturer of both hematoxylin and hematine.

Philadelphia, PA (PRWEB) May 13, 2010 -- Abbey Color Inc., located in Philadelphia, Pennsylvania, USA, announces a joint venture with Mexicana de Extractos International, S.A. de C.V., located in Campeche, Mexico. Mexicana de Extractos has supplied logwood extract to Abbey Color Inc. for their Hematoxylin and Hematine production for over thirty years and the newly formed joint venture, registered as Abbymex, is being built on the strong foundation of mutual respect and trust that has evolved over the years because of the high principles espoused by both companies.

“We are very excited about this venture,” explained Roger Nielsen, President and Owner of Abbey Color Inc. “This investment continues our strategic plan to meet the critical need for Hematoxylin and Hematine in the health industry worldwide. This is a responsibility we take very seriously, and we have demonstrated our commitment through our substantial investment in this joint venture. We are pleased to partner with Mexicana de Extractos, a company of excellent reputation and one which shares our values and our vision. As a result of this venture, our customers throughout the world can purchase their materials, confident in the knowledge that problems with periodic shortages will now be a thing of the past. In accordance with the integrity principles of our combined companies, we have also resolved to maintain a consistent and reasonable pricing structure, as we have done in the past.”

This venture signifies both parties’ dedication to continue supplying hematoxylin to the Hemotoxylin and Eosin Y (H&E) stain markets in North America and throughout the world. Agreements within the formulation of the Abbymex joint venture will ensure continuous and consistent supply of logwood extract to the Abbey Color facility in Philadelphia as to maintain uninterrupted production and inventory building of hematoxylin and hematine.

About Abbey Color Inc.
Abbey Color is a premier dye manufacturer and supplier of industrial dyes, dye precursors and colorants serving various domestic and international markets ranging from healing practices to industrial uses. Abbey Color is the world’s leading manufacturer of hematoxylin and is the only dye manufacturer in the world that makes both hematoxylin and eosin Y. Abbey Color is a supplier to the makers of various biological stain products and hematoxylin is always in stock. Abbey Color's hematoxylin is certified by the Biological Stain Commission (BSC). Hematoxylin is the key ingredient in stains used by biological laboratories and pathologists for Pap smear tests using H&E stain and other procedures. Hematine is used for the dyeing of silk that is used in medical sutures. Abbey Color is a ChemStewards® certified facility.

Contact Abbey Color
For more information or to inquire about Abbey Color’s products and services, including hematoxylin, hematine, logwood extract and biological stain products, please call 215-739-9960 or visit the Abbey Color website at www.AbbeyColor.com.

###

Read the full story at http://www.prweb.com/releases/abbymex/joint-venture/prweb3995624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Exploring gender differences in colorectal cancer screenings
2. Homewatch CareGivers Show in Colorado is Next for SilverStone Group's In-Home Care Team
3. Plastics Color Corporation Expands Into California
4. Three Genes Linked to Variations in Eye Color
5. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
6. Investigators examine colorectal cancer screening methods among diverse populations
7. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
8. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Hispanics live in areas with limited capacity for colorectal cancer screening
11. Leukemia-related protein 16 and colorectal carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex 
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: